FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 69 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $193,256 | -76.6% | 20,472 | -83.2% | 0.00% | -75.0% |
| Q4 2023 | $824,378 | -30.1% | 122,130 | -54.0% | 0.00% | -42.9% |
| Q3 2023 | $1,178,847 | +458.7% | 265,506 | +3446.2% | 0.01% | +600.0% |
| Q3 2021 | $211,000 | +45.5% | 7,487 | -45.7% | 0.00% | 0.0% |
| Q2 2021 | $145,000 | -21.2% | 13,789 | -12.1% | 0.00% | -50.0% |
| Q4 2020 | $184,000 | +41.5% | 15,692 | -4.0% | 0.00% | +100.0% |
| Q3 2020 | $130,000 | -62.0% | 16,339 | -12.6% | 0.00% | -75.0% |
| Q2 2020 | $342,000 | +155.2% | 18,694 | +67.0% | 0.00% | +100.0% |
| Q1 2020 | $134,000 | – | 11,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
| TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
| HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
| Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
| Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
| RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
| Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
| Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
| Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |